Tranexamic Acid Injection 100mg/mL
Prevention and treatment of bleeding due to general or local fibrinolysis in adults and children over 1 year of age, including the following specific indications: Menorrhagia and metrorrhagia (excessive or irregular menstrual bleeding), gastrointestinal bleeding, urinary bleeding disorders following prostate surgery or surgical procedures of the urinary tract, ear, nose, and throat surgery (adenoidectomy, tonsillectomy, dental extractions), gynecological surgery or obstetric-related disorders, thoracic and abdominal surgery, and other major surgical interventions such as cardiovascular surgery, management of bleeding associated with the administration of a fibrinolytic drug.
Pharmaceutical form
Injectable
Concentration
100mg/mL
Combination
N/A
Disclaimer: The content of this website is for pharmaceutical industry professionals interested in creating a strategic alliance with Wexford Laboratories. This page may contain information related to health, medical conditions, physical condition and its treatment. The information contained in this site is not to diagnose a health problem and is not a substitute for the advice provided by your doctor. Always consult a doctor when in doubt about a disease and its treatment. The products are subject to the applicable patent and registration laws of each country, and may not be allowed to be registered in some markets.
